478 related articles for article (PubMed ID: 26386178)
21. Is the PentaBDE replacement, tris (1,3-dichloro-2-propyl) phosphate (TDCPP), a developmental neurotoxicant? Studies in PC12 cells.
Dishaw LV; Powers CM; Ryde IT; Roberts SC; Seidler FJ; Slotkin TA; Stapleton HM
Toxicol Appl Pharmacol; 2011 Nov; 256(3):281-9. PubMed ID: 21255595
[TBL] [Abstract][Full Text] [Related]
22. Bone developmental toxicity of organophosphorus flame retardants TDCIPP and TPhP in marine medaka Oryzias melastigma.
Hong H; Zhao Y; Huang L; Zhong D; Shi D
Ecotoxicol Environ Saf; 2021 Oct; 223():112605. PubMed ID: 34371453
[TBL] [Abstract][Full Text] [Related]
23. Developmental exposure to organophosphate flame retardants elicits overt toxicity and alters behavior in early life stage zebrafish (Danio rerio).
Dishaw LV; Hunter DL; Padnos B; Padilla S; Stapleton HM
Toxicol Sci; 2014 Dec; 142(2):445-54. PubMed ID: 25239634
[TBL] [Abstract][Full Text] [Related]
24. Development of a rat physiologically based kinetic model (PBK) for three organophosphate flame retardants (TDCIPP, TCIPP, TCEP).
Deepika D; Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2023 Jul; 383():128-140. PubMed ID: 37356742
[TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity and risk assessment of brominated and alternative flame retardants.
Hendriks HS; Westerink RH
Neurotoxicol Teratol; 2015; 52(Pt B):248-69. PubMed ID: 26363216
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of organophosphorus flame retardants in indoor dust in multiple microenvironments of southern China and implications for human exposure.
He CT; Zheng J; Qiao L; Chen SJ; Yang JZ; Yuan JG; Yang ZY; Mai BX
Chemosphere; 2015 Aug; 133():47-52. PubMed ID: 25898308
[TBL] [Abstract][Full Text] [Related]
27. Effects of primary metabolites of organophosphate flame retardants on transcriptional activity via human nuclear receptors.
Kojima H; Takeuchi S; Van den Eede N; Covaci A
Toxicol Lett; 2016 Mar; 245():31-9. PubMed ID: 26778350
[TBL] [Abstract][Full Text] [Related]
28. Organophosphorus flame retardants in breast milk from Beijing, China: Occurrence, nursing infant's exposure and risk assessment.
Chen X; Zhao X; Shi Z
Sci Total Environ; 2021 Jun; 771():145404. PubMed ID: 33548720
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the in vitro cyto- and neurotoxicity of brominated and halogen-free flame retardants: prioritization in search for safe(r) alternatives.
Hendriks HS; Meijer M; Muilwijk M; van den Berg M; Westerink RH
Arch Toxicol; 2014 Apr; 88(4):857-69. PubMed ID: 24395120
[TBL] [Abstract][Full Text] [Related]
30. In vitro biolayer interferometry analysis of acetylcholinesterase as a potential target of aryl-organophosphorus flame-retardants.
Shi Q; Guo W; Shen Q; Han J; Lei L; Chen L; Yang L; Feng C; Zhou B
J Hazard Mater; 2021 May; 409():124999. PubMed ID: 33454525
[TBL] [Abstract][Full Text] [Related]
31. Organophosphorus flame retardants and their metabolites in paired human blood and urine.
Guo Y; Chen M; Liao M; Su S; Sun W; Gan Z
Ecotoxicol Environ Saf; 2023 Dec; 268():115696. PubMed ID: 37979363
[TBL] [Abstract][Full Text] [Related]
32. Endocrine disruption potentials of organophosphate flame retardants and related mechanisms in H295R and MVLN cell lines and in zebrafish.
Liu X; Ji K; Choi K
Aquat Toxicol; 2012 Jun; 114-115():173-81. PubMed ID: 22446829
[TBL] [Abstract][Full Text] [Related]
33. [ORGANOPHOSPHORUS FLAME RETARDANTS - TOXICITY AND INFLUENCE ON HUMAN HEALTH].
Bruchajzer E; Frydrych B; Szymańska JA
Med Pr; 2015; 66(2):235-64. PubMed ID: 26294315
[TBL] [Abstract][Full Text] [Related]
34. Estrogenic and growth inhibitory responses to organophosphorus flame retardant metabolites in zebrafish embryos.
Lee JS; Kawai YK; Morita Y; Covaci A; Kubota A
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Jun; 256():109321. PubMed ID: 35227875
[TBL] [Abstract][Full Text] [Related]
35. Multiparameter toxicity assessment of novel DOPO-derived organophosphorus flame retardants.
Hirsch C; Striegl B; Mathes S; Adlhart C; Edelmann M; Bono E; Gaan S; Salmeia KA; Hoelting L; Krebs A; Nyffeler J; Pape R; Bürkle A; Leist M; Wick P; Schildknecht S
Arch Toxicol; 2017 Jan; 91(1):407-425. PubMed ID: 26928308
[TBL] [Abstract][Full Text] [Related]
36. In vitro endocrine disruption potential of organophosphate flame retardants via human nuclear receptors.
Kojima H; Takeuchi S; Itoh T; Iida M; Kobayashi S; Yoshida T
Toxicology; 2013 Dec; 314(1):76-83. PubMed ID: 24051214
[TBL] [Abstract][Full Text] [Related]
37. Effects of tris(1-chloro-2-propyl)phosphate and tris(2-chloroethyl)phosphate on cell viability and morphological changes in peripheral blood mononuclear cells (in vitro study).
Mokra K; Bukowski K; Woźniak K
Hum Exp Toxicol; 2018 Dec; 37(12):1336-1345. PubMed ID: 29945461
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of alternative flame retardants in indoor dust from New Zealand: indoor sources and human exposure assessment.
Ali N; Dirtu AC; Van den Eede N; Goosey E; Harrad S; Neels H; 't Mannetje A; Coakley J; Douwes J; Covaci A
Chemosphere; 2012 Sep; 88(11):1276-82. PubMed ID: 22551874
[TBL] [Abstract][Full Text] [Related]
39. Effects of tris(1,3-dichloro-2-propyl) phosphate and tris(1-chloropropyl) phosphate on cytotoxicity and mRNA expression in primary cultures of avian hepatocytes and neuronal cells.
Crump D; Chiu S; Kennedy SW
Toxicol Sci; 2012 Mar; 126(1):140-8. PubMed ID: 22268003
[TBL] [Abstract][Full Text] [Related]
40. Current-use flame retardants: Maternal exposure and neurodevelopment in children of the CHAMACOS cohort.
Castorina R; Bradman A; Stapleton HM; Butt C; Avery D; Harley KG; Gunier RB; Holland N; Eskenazi B
Chemosphere; 2017 Dec; 189():574-580. PubMed ID: 28963974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
